Research Article
Assessment of Intraoperative Blood Loss during Oral and Maxillofacial Surgical Procedures in a Nigerian Tertiary Health Care Center
Table 1
Age, gender, hematocrit values, and blood requirements of fifty-six (56) patients with 56 procedures on soft tissues.
| | Diagnosis | Number of procedures | Age range | Male (%) | Female (%) | Range,
mean (SD)
pre-PCV | Number of units requested | Number of units used | Range, mean (SD)
post-PCV |
| | Cleft lip | 18 | 2 months–35 years | 9 (6.6) | 9 (6.6) | 21–35,
31.4 (4.1) | 1 | 0 | 27–29,
28 (1.4) | | Cleft palate | 19 | 10 months–28 years | 4 (2.9) | 15 (11.0) | 28–38,
33.9 (3.6) | 1 | 0 | 27–30,
28.3 (1.5) | | Cleft lip and palate | 4 | 5 months–20 years | 2 (1.5) | 2 (1.5) | 25–35,
30.3 (5.0) | 1 | 0 | 24–32,
28.7 (4.2) | | Soft tissue tumors | 9 | 4 months–33 years | 6 (4.4) | 3 (2.2) | 33–46,
39.5 (9.2) | 2 | 1 | 23–44,
33.5 (14.8) | | Malignant soft tissue tumors | 3 | 26–32 years | 2 (1.5) | 1 (0.7) | 25–32,
28.5 (4.9) | 3 | 3 | 34–40,
37.0 (4.2) | | Palatal salivary gland tumors | 3 | 26–41 years | 3 (2.2) | 0 (0) | 30–35,
32.5 (3.5) | 1 | 0 | — | | Total | 56 | — | 26 (18.7) | 30 (21.6) | — | — | — | — |
|
|
